Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
Sellas Life Sciences Group
Sellas Life Sciences Group
Pfizer
Celgene
University of Wisconsin, Madison
AbbVie
University of Kansas Medical Center
Roswell Park Cancer Institute
Novartis
Fox Chase Cancer Center
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center